Tisentotx
2 known investors
Find your way into Tisentotx
Tisento develops pharmaceutical treatments for complex genetic mitochondrial diseases, beginning with MELAS. The company is led by a team of industry veterans focused on improving outcomes for patients with life-altering rare genetic conditions.
Founders & leadership
PH
Peter Hecht, PhDChief Executive Officer
Investors · 2
Frequently asked questions
- What does Tisentotx do?
- Tisento develops pharmaceutical treatments for complex genetic mitochondrial diseases, beginning with MELAS. The company is led by a team of industry veterans focused on improving outcomes for patients with life-altering rare genetic conditions.
- Who are Tisentotx's investors?
- Tisentotx's investors include Sanofi Ventures, Venrock.